20:00
FDA to approves Elevar Therapeutics' Rivoceranib + camrelizumab
22/07
FDA to approves Elevar Therapeutics' Rivoceranib + camrelizumab Ak Pi Bon Bonis nan Championship Haïti
Evènman popilè ak nouvèl sou espò yo
Useful links
Line
Polybet Line
Seleksyone lang